Do ICF Core Sets for Low Back Pain Include Patients' Self-Reported Activity Limitations because of Back Problems?

2013 ◽  
Vol 19 (2) ◽  
pp. 99-107 ◽  
Author(s):  
Hildegunn Lygren ◽  
Liv Inger Strand ◽  
Bodil Anderson ◽  
Liv Heide Magnussen
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Activity Limitations ◽  
Low Back ◽  
Core Sets ◽  
Back Problems ◽  
Icf Core Sets

scholarly journals ICF Core Sets for low back pain

2004 ◽  
Vol 36 (0) ◽  
pp. 69-74 ◽  
Author(s):  
Alarcos Cieza ◽  
Martin Weigl ◽  
Peter Disler ◽  
Sjef van der Linden ◽  
Nenad Kostanjsek ◽  
...  
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Low Back ◽  
Core Sets ◽  
Icf Core Sets

How to Apply the ICF and ICF Core Sets for Low Back Pain

2009 ◽  
Vol 25 (1) ◽  
pp. 29-38 ◽  
Author(s):  
Marita Stier-Jarmer ◽  
Alarcos Cieza ◽  
Michael Borchers ◽  
Gerold Stucki
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Low Back ◽  
Core Sets ◽  
Icf Core Sets

Low-Back Pain Assessment Based on the Brief ICF Core Sets

2008 ◽  
Vol 87 (6) ◽  
pp. 452-460 ◽  
Author(s):  
Birgit Paul ◽  
Christoph Leitner ◽  
Gerda Vacariu ◽  
Franziska Wick ◽  
Sonja Zehetmayer ◽  
...  
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Pain Assessment ◽  
Low Back ◽  
Core Sets ◽  
Icf Core Sets

scholarly journals ICF core sets for low back pain: Do they include what matters to patients?

2007 ◽  
Vol 39 (5) ◽  
pp. 353-357 ◽  
Author(s):  
R Mullis ◽  
J Barber ◽  
M Lewis ◽  
E Hay
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Low Back ◽  
Core Sets ◽  
Icf Core Sets ◽  
What Matters

Mapping of a standard documentation template to the ICF core sets for arthritis and low back pain

2010 ◽  
Vol 15 (4) ◽  
pp. 222-231 ◽  
Author(s):  
Reuben Escorpizo ◽  
Kandace Davis ◽  
Teri Stumbo
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Low Back ◽  
Core Sets ◽  
Standard Documentation ◽  
Icf Core Sets

Poster 216: Relevance of Motor Performance and Psychologic Tests to Low Back Pain Assessment Based on the Brief ICF Core Sets

2007 ◽  
Vol 88 (9) ◽  
pp. E71-E72
Author(s):  
Birgit Paul ◽  
Christoph Leitner ◽  
Sonja Zehetmayer ◽  
Erich Vanecek ◽  
Gerold R. Ebenbichler
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Pain Assessment ◽  
Motor Performance ◽  
Low Back ◽  
Core Sets ◽  
Icf Core Sets

scholarly journals Intervertebral disc therapies for non-specific chronic low back pain: a systematic review and meta-analysis

2021 ◽  
Vol 13 ◽  
pp. 1759720X2110280
Author(s):  
Camille Daste ◽  
Stéphanie Laclau ◽  
Margaux Boisson ◽  
François Segretin ◽  
Antoine Feydy ◽  
...  
Keyword(s):  
Systematic Review ◽  
Low Back Pain ◽  
Back Pain ◽  
Intervertebral Disc ◽  
Chronic Low Back Pain ◽  
Meta Analysis ◽  
Activity Limitations ◽  
Low Back ◽  
Short Term

Objectives: We aim to evaluate the benefits and harms of intervertebral disc therapies (IDTs) in people with non-specific chronic low back pain (NScLBP). Methods: We conducted a systematic review and meta-analysis of randomized trials of IDTs versus placebo interventions, active comparators or usual care. EMBASE, MEDLINE, CENTRAL and CINHAL databases and conference abstracts were searched from inception to June 2020. Two independent investigators extracted data. The primary outcome was LBP intensity at short term (1 week–3 months), intermediate term (3–6 months) and long term (after 6 months). Results: Of 18 eligible trials (among 1396 citations), five assessed glucocorticoids (GCs) IDTs and were included in a quantitative synthesis; 13 assessed other products including etanercept ( n = 2), tocilizumab ( n = 1), methylene blue ( n = 2), ozone ( n = 2), chymopapaine ( n = 1), glycerol ( n = 1), stem cells ( n = 1), platelet-rich plasma ( n = 1) and recombinant human growth and differentiation factor-5 ( n = 2), and were included in a narrative synthesis. Standardized mean differences (95% CI) for GC IDTs for LBP intensity and activity limitations were −1.33 (−2.34; −0.32) and −0.76 (−1.85; 0.34) at short term, −2.22 (−5.34; 0.90) and −1.60 (−3.51; 0.32) at intermediate term and −1.11 (−2.91; 0.70) and −0.63 (−1.68; 0.42) at long term, respectively. Odds ratios (95% CI) for serious and minor adverse events with GC IDTs were 1.09 (0.25; 4.65) and 0.97 (0.49; 1.91). Conclusion: GC IDTs are associated with a reduction in LBP intensity at short term in people with NScLBP. Positive effects are not sustained. IDTs have no effect on activity limitations. Our conclusions are limited by high heterogeneity and a limited methodological quality across studies. Registration PROSPERO: CRD42019106336.

Sign in / Sign up

Export Citation Format

Share Document